Apyx Medical Corp APYX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APYX is a good fit for your portfolio.
News
-
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
-
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
-
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
-
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
-
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
-
Apyx Medical Gets FDA Clearance for Renuvion Micro Handpiece
Trading Information
- Previous Close Price
- $1.32
- Day Range
- $1.26–1.39
- 52-Week Range
- $1.21–7.97
- Bid/Ask
- $1.25 / $2.19
- Market Cap
- $47.81 Mil
- Volume/Avg
- 66,774 / 164,864
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.92
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 252
- Website
- https://apyxmedical.com
Comparables
Valuation
|
Metric
|
APYX
|
MMSI
|
ZIMV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 23.60 | 9.61 |
Price/Book Value | 1.80 | 3.42 | 1.04 |
Price/Sales | 0.92 | 3.30 | 0.91 |
Price/Cash Flow | — | 19.27 | 12.19 |
Price/Earnings
APYX
MMSI
ZIMV
Financial Strength
|
Metric
|
APYX
|
MMSI
|
ZIMV
|
|---|---|---|---|
Quick Ratio | 4.53 | 3.81 | 0.84 |
Current Ratio | 5.52 | 5.45 | 2.78 |
Interest Coverage | −7.96 | 8.07 | −1.51 |
Quick Ratio
APYX
MMSI
ZIMV
Profitability
|
Metric
|
APYX
|
MMSI
|
ZIMV
|
|---|---|---|---|
Return on Assets (Normalized) | −26.17% | 9.43% | 14.12% |
Return on Equity (Normalized) | −47.60% | 14.77% | 31.63% |
Return on Invested Capital (Normalized) | −29.80% | 11.47% | 18.79% |
Return on Assets
APYX
MMSI
ZIMV
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Kctpqlktg | Cxbnjd | $182.7 Bil | |
SYK
| Stryker Corp | Ljpstlyxbg | Rmyp | $124.6 Bil | |
MDT
| Medtronic PLC | Klmkxcz | Fxwqf | $105.2 Bil | |
BSX
| Boston Scientific Corp | Dsgkncg | Ntyvslh | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Nqsnyylsj | Rdnnk | $52.0 Bil | |
DXCM
| DexCom Inc | Gqjcndbsw | Sykw | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jvcsfzgg | Yvjgb | $24.5 Bil | |
ALGN
| Align Technology Inc | Cgnwjmdg | Spszjbx | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Rmrlmlfj | Djvlppf | $18.3 Bil | |
PODD
| Insulet Corp | Jhkyxdrfw | Yjxrwmz | $11.6 Bil |